Fact CheckerSign in

NCT06033508Completed

Effects of Whole-body Vibration Therapy on Type 2 Diabetic Patients with and Without Polyneuropathy

Source: ClinicalTrials.gov · Last updated 6 Feb 2025

Brief summary (registry, in English)

The aim of this study is to show how whole body vibration training practiced for 12 weeks affects the levels of inflammatory biomarkers such as C reactive protein (CRP) and, interleukin-6 (IL-6), in Type 2 diabetic patients (T2DM) with and without peripheral neuropathy.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
5 Sept 2023
Start date
1 Apr 2024
Primary completion date
1 Nov 2024
Lead sponsor
Pamukkale University
NCT number
NCT06033508

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Apr 2024 to the primary completion date, 1 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • T2DM patients who carry a pacemaker, prosthesis, intrauterine device or metal implant,
  • T2DM patients who are on psychotropic or neurotoxic therapy
  • T2DM patients who are organ transplant recipients

Other illness

  • T2DM patients with advanced cardiovascular, renal, hepatic disease
  • T2DM patients with untreated hypertension, rhythm disorders, and those who have undergone bypass surgery
  • T2DM patients with inflammatory rheumatic diseases such as rheumatoid arthritis
  • T2DM patients with active infectious disease
  • T2DM patients with high risk of thrombosis, those with deep vein thrombosis
  • T2DM patients with a history of cancer
  • T2DM patients with severe migraine, epilepsy, stroke or other neurological disorders, those who have undergone brain surgery
  • T2DM patients with non-diabetic neuropathy due to reasons such as HIV, AIDS, alcohol, uremia
  • T2DM patients with cognitive impairment

Other

  • T2DM patients with diabetic retinopathy or nephropathy
  • T2DM patients with ischemic changes in the resting ECG
  • T2DM patients with untreated hypoglycemia or orthostatic hypotension
  • T2DM patients who are unable to walk independently, or use of canes, crutches or wheelchairs
  • T2DM patients who have open ulcers or wounds on load-bearing surfaces
  • T2DM patients with advanced balance problems
  • T2DM patients who are pregnant or breastfeeding mothers
  • T2DM patients with hernia
  • T2DM patients with kidney or bladder stones
  • T2DM patients who are exposed to mechanical vibration due to their job

Who the study is looking for

  • Participants must stand and walk o without using an assistive device.
  • Participants must have a weight of less than 120 kg.

Age in the registry: 30 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pamukkale University
Coordinator of this site? Confirm its status
DenizliTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.